A Phase I Trial of Prolonged Oral Etoposide and Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study

Peter G. Rose; Michael Rodriguez; Joan Walker; Benjamin Greer; Nancy Fusco; William McGuire

doi:10.1006/gyno.2002.6584

A Phase I Trial of Prolonged Oral Etoposide and Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2002.6584 ◽

2002 ◽

Vol 85 (1) ◽

pp. 136-139 ◽

Cited By ~ 7

Author(s):

Peter G. Rose ◽

Michael Rodriguez ◽

Joan Walker ◽

Benjamin Greer ◽

Nancy Fusco ◽

...

Keyword(s):

Phase I ◽

Phase I Trial ◽

Liposomal Doxorubicin ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oral Etoposide ◽

Oncology Group ◽

Oncology Group Study

Get full-text (via PubEx)

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.11.024 ◽

2016 ◽

Vol 140 (2) ◽

pp. 204-209 ◽

Cited By ~ 22

Author(s):

Lisa M. Landrum ◽

William E. Brady ◽

Deborah K. Armstrong ◽

Kathleen N. Moore ◽

Paul A. DiSilvestro ◽

...

Keyword(s):

Phase I ◽

Phase I Trial ◽

Liposomal Doxorubicin ◽

Gynecologic Oncology ◽

Pegylated Liposomal Doxorubicin ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Fallopian Tube Cancer ◽

Oncology Group Study ◽

Platinum Sensitive

Get full-text (via PubEx)

A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.08.001 ◽

2017 ◽

Vol 147 (2) ◽

pp. 283-290 ◽

Cited By ~ 13

Author(s):

Premal H. Thaker ◽

William E. Brady ◽

Heather A. Lankes ◽

Kunle Odunsi ◽

William H. Bradley ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Trial ◽

Liposomal Doxorubicin ◽

Gynecologic Oncology ◽

Pegylated Liposomal Doxorubicin ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Get full-text (via PubEx)

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.053 ◽

2015 ◽

Vol 137 ◽

pp. 23

Author(s):

L.M. Landrum ◽

W.E. Brady ◽

D.K. Armstrong ◽

K.N. Moore ◽

P.A. DiSilvestro ◽

...

Keyword(s):

Phase I ◽

Phase I Trial ◽

Liposomal Doxorubicin ◽

Gynecologic Oncology ◽

Pegylated Liposomal Doxorubicin ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Fallopian Tube Cancer ◽

Oncology Group Study ◽

Platinum Sensitive

Get full-text (via PubEx)

A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.08.030 ◽

2012 ◽

Vol 127 (3) ◽

pp. 456-461 ◽

Cited By ~ 23

Author(s):

Kathleen N. Moore ◽

Michael W. Sill ◽

David S. Miller ◽

Carolyn McCourt ◽

Koen De Geest ◽

...

Keyword(s):

Cervical Cancer ◽

Radiation Therapy ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Get full-text (via PubEx)

Phase I Trial of Ifosfamide and 24-h Infusional Paclitaxel in Pelvic Malignancies: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2000.6107 ◽

2001 ◽

Vol 80 (3) ◽

pp. 359-363 ◽

Cited By ~ 2

Author(s):

Maurie Markman ◽

David Spriggs ◽

Robert A. Burger ◽

Linda F. Carson ◽

Samuel S. Lentz ◽

...

Keyword(s):

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Pelvic Malignancies

Get full-text (via PubEx)

Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.09.015 ◽

2009 ◽

Vol 112 (1) ◽

pp. 134-141 ◽

Cited By ~ 3

Author(s):

D. Scott McMeekin ◽

Joan L. Walker ◽

Ellen M. Hartenbach ◽

Michael A. Bookman ◽

Wui-Jin Koh

Keyword(s):

Radiation Therapy ◽

Endometrial Cancer ◽

High Risk ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Get full-text (via PubEx)

A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer®) in recurrent ovarian cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.02.029 ◽

2006 ◽

Vol 103 (2) ◽

pp. 391-396 ◽

Cited By ~ 48

Author(s):

Deborah K. Armstrong ◽

Gini F. Fleming ◽

Maurie Markman ◽

Howard H. Bailey

Keyword(s):

Ovarian Cancer ◽

Sustained Release ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Recurrent Ovarian Cancer ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Get full-text (via PubEx)

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.05.020 ◽

2010 ◽

Vol 118 (3) ◽

pp. 303-307 ◽

Cited By ~ 4

Author(s):

Amy D. Tiersten ◽

Michael W. Sill ◽

Danielle Knight ◽

Franco Muggia ◽

Agustin A. Garcia ◽

...

Keyword(s):

Phase I ◽

Feasibility Study ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Dose Dense

Get full-text (via PubEx)

A phase I trial of gemcitabine and topotecan in previously treated ovarian or peritoneal cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.07.114 ◽

2006 ◽

Vol 100 (1) ◽

pp. 111-115 ◽

Cited By ~ 3

Author(s):

M. Dwight Chen ◽

Gini F. Fleming ◽

Suann Mitchell ◽

Ira Horowitz

Keyword(s):

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Peritoneal Cancer ◽

Previously Treated

Get full-text (via PubEx)

Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin–cisplatin followed by whole abdomen irradiation

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.11.026 ◽

2009 ◽

Vol 112 (3) ◽

pp. 553-557 ◽

Cited By ~ 13

Author(s):

Jeffrey M. Fowler ◽

William E. Brady ◽

Perry W. Grigsby ◽

David E. Cohn ◽

Robert S. Mannel ◽

...

Keyword(s):

Endometrial Cancer ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Advanced Stage ◽

Oncology Group ◽

Sequential Chemotherapy

Get full-text (via PubEx)